-
1
-
-
0037847510
-
Characterization of the effects of pancreatic poypeptide in the regulation of energy balance
-
Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M, Fujino MA, Niijima A, Meguid MM, Kasuga M. Characterization of the effects of pancreatic poypeptide in the regulation of energy balance. Gastroenterology 2003;124:1325-1336.
-
(2003)
Gastroenterology
, vol.124
, pp. 1325-1336
-
-
Asakawa, A.1
Inui, A.2
Yuzuriha, H.3
Ueno, N.4
Katsuura, G.5
Fujimiya, M.6
Fujino, M.A.7
Niijima, A.8
Meguid, M.M.9
Kasuga, M.10
-
2
-
-
0028139089
-
Positional cloning of the mouse obese gene and its human homologue
-
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
-
(1994)
Nature
, vol.372
, pp. 425-432
-
-
Zhang, Y.1
Proenca, R.2
Maffei, M.3
Barone, M.4
Leopold, L.5
Friedman, J.M.6
-
3
-
-
0036161876
-
Distribution of pancreatic polypeptide and peptide YY
-
Ekblad E, Sunbdler F. Distribution of pancreatic polypeptide and peptide YY. Peptides 2002;23:251-261.
-
(2002)
Peptides
, vol.23
, pp. 251-261
-
-
Ekblad, E.1
Sunbdler, F.2
-
4
-
-
0031919929
-
XV1 International Union of Pharmacology recommendations for the nomenclature of Neuropeptide Y, peptide YY and pancreatic polypeptide receptors
-
Michel MC, Beck-Stickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quiron R, Schwartz T, Westfall T. XV1 International Union of Pharmacology recommendations for the nomenclature of Neuropeptide Y, peptide YY and pancreatic polypeptide receptors. Pharmacol Rev 1998;50:143-150.
-
(1998)
Pharmacol Rev
, vol.50
, pp. 143-150
-
-
Michel, M.C.1
Beck-Stickinger, A.2
Cox, H.3
Doods, H.N.4
Herzog, H.5
Larhammar, D.6
Quiron, R.7
Schwartz, T.8
Westfall, T.9
-
7
-
-
0037443099
-
Orexin neurons express a functional pancreatic poypetide Y4 receptor
-
Campbell RE, Smith MS, Allen SE, Grayson BE, French-Mullen JMH, Grave KL. Orexin neurons express a functional pancreatic poypetide Y4 receptor. J Neurosci 2003;23:1487-1497.
-
(2003)
J Neurosci
, vol.23
, pp. 1487-1497
-
-
Campbell, R.E.1
Smith, M.S.2
Allen, S.E.3
Grayson, B.E.4
French-Mullen, J.M.H.5
Grave, K.L.6
-
8
-
-
0037043704
-
Gut hormone PYY(3-36) physiologically inhibits food intake
-
Batterham RL, Cowley MAS, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low ML, Ghatel MA, Cone RD, Bloom SB. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002;418:650-654.
-
(2002)
Nature
, vol.418
, pp. 650-654
-
-
Batterham, R.L.1
Cowley, M.A.S.2
Small, C.J.3
Herzog, H.4
Cohen, M.A.5
Dakin, C.L.6
Wren, A.M.7
Brynes, A.E.8
Low, M.L.9
Ghatel, M.A.10
Cone, R.D.11
Bloom, S.B.12
-
9
-
-
0030873354
-
Distribution of pancreatic polypeptide receptors in the rat brain
-
Whitcomb DC, Puccio AM, Vigna SR, Taylor H, Hoffman GE. Distribution of pancreatic polypeptide receptors in the rat brain. Brain Res 1997;760:137-149.
-
(1997)
Brain Res
, vol.760
, pp. 137-149
-
-
Whitcomb, D.C.1
Puccio, A.M.2
Vigna, S.R.3
Taylor, H.4
Hoffman, G.E.5
-
10
-
-
0033781032
-
Cholecystokinin and satiety: Current perspectives
-
Moran TH. Cholecystokinin and satiety: current perspectives. Nutrition 2000;16:858-865.
-
(2000)
Nutrition
, vol.16
, pp. 858-865
-
-
Moran, T.H.1
-
11
-
-
0027190603
-
Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome
-
Bernston GG, Zipf WB, O'Dorsio TM, Hoffman JA, Chance RE. Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome. Peptides 1993;14:497-503.
-
(1993)
Peptides
, vol.14
, pp. 497-503
-
-
Bernston, G.G.1
Zipf, W.B.2
O'Dorsio, T.M.3
Hoffman, J.A.4
Chance, R.E.5
-
12
-
-
0036061558
-
Elevated plasma ghrelin levels in Prader-Willi syndrome
-
Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS. Elevated plasma ghrelin levels in Prader-Willi syndrome. Nature Medicine 2002;8:643-644.
-
(2002)
Nature Medicine
, vol.8
, pp. 643-644
-
-
Cummings, D.E.1
Clement, K.2
Purnell, J.Q.3
Vaisse, C.4
Foster, K.E.5
Frayo, R.S.6
Schwartz, M.W.7
Basdevant, A.8
Weigle, D.S.9
|